exploratory and non-compartmental analyses of pk pd data
Published 4 years ago • 1K plays • Length 1:06:50Download video MP4
Download video MP3
Similar videos
-
3:18
the benefits of using pharmacokinetic and pharmacodynamic modeling
-
52:51
pharmacodynamic and pharmacokinetic modeling of data with dr. joga gobburu
-
1:01:17
noncompartmental vs. compartmental approaches to pharmacokinetic analysis with dr. paolo vicini
-
2:17
noncompartmental data analysis
-
6:26
overview of pk-pd relationship / drug dynamic
-
22:04
pharmacokinetics - what your body does to the med - quick review - pharmacology series
-
39:48
dr joseph standing: understanding and applying pkpd concepts in your clinical practice
-
14:25
pharmacokinetics: absorption, distribution, metabolism & excretion
-
0:58
pkplus 2 noncompartmental (nca) & compartmental pk modeling
-
1:12:56
changes to population pk/pd data and supplemental information based on fda guidance for poppk
-
22:12
pk/pd modeling exercise with dr. cody j. peer
-
20:05
dr. sebastian benzekry - examples of pharmacometrics studies in preclinical and clinical oncology
-
5:50
pharmacokinetics 1 - introduction
-
1:22:09
population pharmacokinetics with dr. robert r. bies
-
30:46
physiologically based pharmacokinetic modeling for the simulation of relevant clinical scenarios
-
28:51
pharmacometrics in phase 1: first in human and dose selection for phase 2
-
27:12
dr sam salman pharmacokinetic modelling non compartemental analysis vs population pharmacokinetic
-
3:11
pharmacometrics using r: pkpdsim walkthrough part 1
-
0:40
clinical cuts: pharmacodynamics - agonist, partial agonist, antagonist
-
31:10
lecture 1 introduction to pharmacokinetics
-
20:56
pharmacometrics in phase 3 – data integration and analysis to support dose and labeling for the nda